{
  "$schema": "https://example.com/risky-biotech.schema.json",
  "roster": [
    {
      "name": "GeneScale Therapeutics",
      "founders": [
        {
          "name": "Dr. Sahana Patel",
          "degree": "PhD",
          "school": "MIT"
        },
        {
          "name": "Dr. Kai Nakamura",
          "degree": "PhD",
          "school": "Tokyo University"
        }
      ],
      "mission": "Developing modular gene therapies that scale to mainstream patients.",
      "founding_location": "Cambridge, MA",
      "ipo_window": {
        "from": 2000,
        "to": 2003
      }
    },
    {
      "name": "Synaptix",
      "founders": [
        {
          "name": "Dr. Elise Carver",
          "degree": "MD",
          "school": "Johns Hopkins"
        },
        {
          "name": "Dr. Malik Hassan",
          "degree": "PhD",
          "school": "Oxford"
        }
      ],
      "mission": "Creating immune therapies for brain disease.",
      "founding_location": "Baltimore, MD",
      "ipo_window": {
        "from": 1999,
        "to": 2006
      }
    },
    {
      "name": "OncoGen",
      "founders": [
        {
          "name": "Dr. Lucia Romero",
          "degree": "PhD",
          "school": "Stanford"
        },
        {
          "name": "Dr. Noah Bernstein",
          "degree": "MD",
          "school": "Harvard"
        }
      ],
      "mission": "Targeted cancer diagnostics and therapies.",
      "founding_location": "San Diego, CA",
      "ipo_window": {
        "from": 1992,
        "to": 1997
      }
    }
  ],
  "pipelineTemplate": [
    {
      "id": "pan_cancer_immunotherapy",
      "label": "Pan-cancer Immunotherapy",
      "full_revenue_usd": 40000000000,
      "stages": [
        {
          "id": "phase_1",
          "name": "Phase 1 Trials",
          "duration_days": 730,
          "success_prob": 0.26,
          "value_realization": 0.15,
          "cost_usd": 120000000,
          "max_retries": 2
        },
        {
          "id": "phase_2",
          "name": "Phase 2 Trials",
          "duration_days": 1095,
          "depends_on": "phase_1",
          "success_prob": 0.41,
          "value_realization": 0.3,
          "cost_usd": 220000000,
          "max_retries": 2
        },
        {
          "id": "phase_3",
          "name": "Phase 3 Trials",
          "duration_days": 1460,
          "depends_on": "phase_2",
          "success_prob": 0.58,
          "value_realization": 0.4,
          "cost_usd": 380000000,
          "max_retries": 1
        },
        {
          "id": "fda_review",
          "name": "FDA Review",
          "duration_days": 365,
          "depends_on": "phase_3",
          "success_prob": 0.78,
          "value_realization": 0.15,
          "cost_usd": 110000000,
          "max_retries": 1,
          "commercialises_revenue": true
        }
      ]
    }
  ],
  "defaults": {
    "structural_bias": {
      "min": 0.2,
      "max": 6,
      "half_life_years": 25
    },
    "margin_curve": {
      "start_profit_margin": [
        0.08,
        0.15
      ],
      "terminal_profit_margin": [
        0.5,
        0.7
      ],
      "years_to_mature": [
        10,
        14
      ]
    },
    "multiple_curve": {
      "initial_ps_ratio": [
        28,
        45
      ],
      "terminal_pe_ratio": [
        16,
        22
      ],
      "years_to_converge": [
        8,
        12
      ]
    },
    "sector": "Biotech",
    "initial_revenue_usd": {
      "min": [
        1000000,
        5000000
      ],
      "maxMultiplier": [
        4,
        8
      ]
    },
    "pipeline_scale": [
      0.75,
      1.25
    ]
  }
}